Peer reviewed
Continued treatment with tirzepatide for maintenance of weight reduction
SURMOUNT-4 randomized withdrawal trial evaluating continued tirzepatide treatment versus placebo.
JAMAPublished Dec 11, 2023Accessed Jul 12, 2026
Registry record
Source metadata
- Publisher
- JAMA
- Source type
- Peer reviewed
- Registry ID
jama-surmount4-withdrawal-2023
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.